top of page

Examining the Health Benefits of Probiotics: Understanding the Role of Gut Microbiota

Jun 12, 20235 min read

The human gut is home to trillions of microorganisms that collectively form the gut microbiota. Among these microorganisms, bacteria play a crucial role in maintaining overall health and well-being. Probiotics - live microorganisms that confer health benefits to the host when administered in adequate amounts - have gained considerable attention in recent years. This article explores the health benefits of probiotics, focusing on the different types of bacteria and their role in promoting gut health.


Understanding the Gut Microbiota

The gut microbiota is a diverse ecosystem comprising hundreds of bacterial species. These bacteria form a symbiotic relationship with the human body, aiding in digestion, nutrient absorption, and immune system modulation. The balance and diversity of the gut microbiota are essential for maintaining overall health.


Types of Beneficial Bacteria:

  • Lactobacillus: Lactobacillus species are among the most commonly studied and utilized probiotics. They can be found in various fermented foods, such as yoghurt and sauerkraut. Lactobacillus strains have been shown to enhance immune function, improve lactose digestion, and alleviate symptoms of irritable bowel syndrome (IBS).

  • Bifidobacterium: Bifidobacterium species are predominant in the gut microbiota of breastfed infants. These bacteria have been associated with numerous health benefits, including enhanced immune response, prevention of gastrointestinal infections, and improved bowel regularity. Bifidobacterium strains also aid in the production of certain vitamins and short-chain fatty acids.

  • Streptococcus: Streptococcus strains, particularly Streptococcus thermophilus, are commonly used in the production of dairy products. They contribute to lactose digestion, reduce the risk of antibiotic-associated diarrhoea, and promote gut barrier function.

  • Escherichia coli: While some strains of Escherichia coli (E. coli) are pathogenic, certain non-pathogenic strains have demonstrated probiotic properties. These strains help maintain the intestinal epithelial barrier, modulate the immune system, and produce beneficial metabolites.

  • Saccharomyces boulardii: Although not a bacterial species, Saccharomyces boulardii is a yeast with probiotic properties. It has been extensively studied for its efficacy in preventing and treating antibiotic-associated diarrhoea, Clostridium difficile infection, and various other gastrointestinal disorders.

Mechanisms of Action

Probiotics exert their health benefits through multiple mechanisms:


Competitive Exclusion: Probiotics compete with pathogenic bacteria for adhesion sites in the gut, preventing colonization by harmful microorganisms.


Modulation of Immune Response: Probiotics interact with the immune system, promoting the production of anti-inflammatory cytokines and enhancing immune defence against pathogens.


Enhancement of Gut Barrier Function: Probiotics strengthen the intestinal epithelial barrier, preventing the translocation of harmful substances and pathogens into the bloodstream.


Production of Beneficial Metabolites: Certain probiotic strains produce short-chain fatty acids, vitamins, and other bioactive compounds that contribute to overall gut health.


Health Benefits of Probiotics

  1. Digestive Health: Probiotics have been shown to alleviate symptoms of gastrointestinal disorders, such as IBS, inflammatory bowel disease (IBD), and antibiotic-associated diarrhoea. They can also improve bowel regularity and reduce the risk of constipation.

  2. Immune Function: Probiotics enhance the body's immune response, reducing the incidence and severity of respiratory and gastrointestinal infections. They may also have a positive impact on allergies and autoimmune diseases.

  3. Mental Health: Emerging evidence suggests a link between the gut microbiota and mental health. Probiotics have shown potential in alleviating symptoms of anxiety, depression, and stress-related disorders.

  4. Metabolic Health: Probiotics may contribute to weight management, reduce the risk of obesity, and improve glucose and lipid metabolism. They can also help control appetite and regulate satiety hormones.

Conclusion

Probiotics, especially those containing Lactobacillus, Bifidobacterium, Streptococcus, Escherichia coli, and Saccharomyces boulardii, have demonstrated numerous health benefits. By modulating the gut microbiota and influencing various physiological processes, these beneficial bacteria contribute to overall gut health, immune function, mental well-being, and metabolic balance. Incorporating probiotic-rich foods or supplements into our diet can be a valuable strategy for maintaining and promoting our overall health.


n.b. This subject is such an interesting one for me personally! I'll be doing a few follow-up pieces to dive into the detail, but, if you want to read more of the scientific literature, I've included some references below:

  1. Hill C, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.

  2. FAO/WHO. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April - 1 May 2002.

  3. Parvez S, Malik KA, Kang SA, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006;100(6):1171-1185.

  4. Hill C, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514.

  5. Sanders ME, Merenstein DJ, Ouwehand AC, et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16(10):605-616.

  6. Huang R, Wang K, Hu J. Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;8(8):483.

  7. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(5):755-764.

  8. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470-1481.

  9. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761-1772.

  10. Zhang Y, Li X, Zou Q, et al. Probiotic bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiol Immunol. 2019;63(6):239-248.

  11. McFarland LV. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 2014;4(8):e005047.

  12. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015;60 Suppl 2:S129-S134.

  13. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhoea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-1969.

  14. Shen NT, Maw A, Tmanova LL, et al. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology. 2017;152(8):1889-1900.e9.

  15. Floch MH, Walker WA, Guandalini S, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011;45 Suppl:S168-S171.

  16. Reid G, Jass J, Sebulsky MT, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003;16(4):658-672.

  17. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. 2019;25(5):716-729.

  18. Grover M, Kashyap PC. Germ-free mice as a model to study effect of gut microbiota on host physiology. Neurogastroenterol Motil. 2014;26(6):745-748.

  19. Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J. 2004;80(947):516-526.

  20. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361(9356):512-519.

  21. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80 Suppl 1:S147-S171.

  22. Saulnier DM, Gibson GR, Kolida S. Microbiology of the human intestinal tract and approaches for its dietary modulation. Curr Pharm Des. 2009;15(13):1403-1414.

  23. O'Sullivan DJ. Methods for analysis of the intestinal microflora. Curr Issues Intest Microbiol. 2000;1(1):39-50.

  24. Petrof EO, Claud EC, Gloor GB, et al. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes. 2013;4(1):53-65.

  25. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136(1):65-80.

  26. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017;9(9):1021.

  27. Petrof EO, Gloor GB, Vanner SJ, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome. 2013;1(1):3.

  28. Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behaviour. Neurogastroenterol Motil. 2011;23(3):187-192.

  29. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012;37(9):1369-1378.

  30. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720-726.



 

Yorumlar

bottom of page